Marc A Schneider (Marc Schneider, M A Schneider)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 18

Top Venues

Cancers

Antioxidants (Basel, Switzerland)

Biomedicines

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Tommaso A Dragani, Thomas Muley, Marc A Schneider, Sonja Kobinger, Martin Eichhorn, Hauke Winter, Hans Hoffmann, Mark Kriegsmann, Sara Noci, Matteo Incarbone, Davide Tosi, Sara Franzi, Francesca Colombo
Lung Adenocarcinoma Diagnosed at a Younger Age Is Associated with Advanced Stage, Female Sex, and Ever-Smoker Status, in Patients Treated with Lung Resection. Cancers 15 (8) (2023)
Tommaso A Dragani, Thomas Muley, Marc A Schneider, Sonja Kobinger, Martin Eichhorn, Hauke Winter, Hans Hoffmann, Mark Kriegsmann, Sara Noci, Matteo Incarbone, Davide Tosi, Sara Franzi, Francesca Colombo
Lung Adenocarcinoma Diagnosed at a Younger Age Is Associated with Advanced Stage, Female Sex, and Ever-Smoker Status, in Patients Treated with Lung Resection. Cancers 15 (8) (2023)
C Veith, Marc A Schneider, L Maas, A van der Vliet, F J van Schooten, M Kreuter, M Meister, A W Boots, N Kahn
Differences in Treatment Response in Bronchial Epithelial Cells from Idiopathic Pulmonary Fibrosis (IPF) Patients: A First Step towards Personalized Medicine? Antioxidants (Basel, Switzerland) 12 (2) (2023)
C Veith, Marc A Schneider, L Maas, A van der Vliet, F J van Schooten, M Kreuter, M Meister, A W Boots, N Kahn
Differences in Treatment Response in Bronchial Epithelial Cells from Idiopathic Pulmonary Fibrosis (IPF) Patients: A First Step towards Personalized Medicine? Antioxidants (Basel, Switzerland) 12 (2) (2023)
Karla Rubio, Jason M Müller, Aditi Mehta, Iris Watermann, Till Olchers, Ina Koch, Sabine Wessels, Marc A Schneider, Tania Araujo-Ramos, Indrabahadur Singh, Christian Kugler, Mircea-Gabriel Stoleriu, Mark Kriegsmann, Martin Eichhorn, Thomas Muley, Olivia M Merkel, Thomas Braun, Ole Ammerpohl, Martin Reck, Achim Tresch, Guillermo Barreto
Preliminary results from the EMoLung clinical study showing early lung cancer detection by the LC score. Discover. Oncology 14 (1) (2023)
Stephanie J Yaung, Corinna Woestmann, Christine Ju, Xiaoju Max Ma, Sandeep Gattam, Yiyong Zhou, Liu Xi, Subrata Pal, Aarthi Balasubramanyam, Nalin Tikoo, Claus Peter Heussel, Michael Thomas, Mark Kriegsmann, Michael Meister, Marc A Schneider, Felix J Herth, Birgit Wehnl, Maximilian Diehn, Ash A Alizadeh, John F Palma, Thomas Muley
Early Assessment of Chemotherapy Response in Advanced Non-Small Cell Lung Cancer with Circulating Tumor DNA. Cancers 14 (10) (2022)
Anna Ricarda Gründing, Marc A Schneider, Sarah Richtmann, Mark Kriegsmann, Hauke Winter, Beatriz Martinez Delgado, Sarai Varona, Bin Liu, David S DeLuca, Julia Held, Sabine Wrenger, Thomas Muley, Michael Meister, Tobias Welte, Sabina Janciauskiene
Lung Adenocarcinoma Cell Sensitivity to Chemotherapies: A Spotlight on Lipid Droplets and SREBF1 Gene. Cancers 14 (18) (2022)
Vivienne Theobald, Nicola Benjamin, Hans-Jürgen Seyfarth, Michael Halank, Marc A Schneider, Sarah Richtmann, Katrin Hinderhofer, Panagiota Xanthouli, Benjamin Egenlauf, Rebekka Seeger, Marius M Hoeper, Danny D Jonigk, Ekkehard Grünig, Christina A Eichstaedt
Reduction of BMPR2 mRNA Expression in Peripheral Blood of Pulmonary Arterial Hypertension Patients: A Marker for Disease Severity? Genes 13 (5) (2022)
Louisa Bühler, Markus D Enderle, Nicolas Kahn, Markus Polke, Marc A Schneider, Claus Peter Heußel, Felix J F Herth, Walter Linzenbold
Establishment of a Tissue-Mimicking Surrogate for Pulmonary Lesions to Improve the Development of RFA Instruments and Algorithms. Biomedicines 10 (5) (2022)
Timo B Trefzer, Marc A Schneider, Katharina Jechow, Robert Lorenz Chua, Thomas Muley, Hauke Winter, Mark Kriegsmann, Michael Meister, Roland Eils, Christian Conrad
Intratumoral Heterogeneity and Immune Modulation in Lung Adenocarcinoma in Female Smokers and Never Smokers. Cancer research 82 (17) (2022)
Maria Joana Catarata, Rui Medeiros, Maria José Oliveira, Alice Pêgo, João Gonçalo Frade, Maria Fátima Martins, Carlos Robalo Cordeiro, Felix J F Herth, Michael Thomas, Mark Kriegsmann, Michael Meister, Marc A Schneider, Thomas Muley, Ricardo Ribeiro
Germline Genetic Variants of the Renin-Angiotensin System, Hypoxia and Angiogenesis in Non-Small Cell Lung Cancer Progression: Discovery and Validation Studies. Cancers 12 (12) (2020)
Miriam M Küster, Marc A Schneider, Antje M Richter, Sarah Richtmann, Hauke Winter, Mark Kriegsmann, Soni Savai Pullamsetti, Thorsten Stiewe, Soni Savai Pullamsetti, Thomas Muley, Reinhard H Dammann
Epigenetic Inactivation of the Tumor Suppressor IRX1 Occurs Frequently in Lung Adenocarcinoma and Its Silencing Is Associated with Impaired Prognosis. Cancers 12 (12) (2020)
Florian Janke, Farastuk Bozorgmehr, Sabine Wrenger, Steffen Dietz, Claus P Heussel, Gudula Heussel, Carlos F Silva, Stephan Rheinheimer, Manuel Feisst, Michael Thomas, Heiko Golpon, Andreas Günther, Holger Sültmann, Thomas Muley, Sabina Janciauskiene, Michael Meister, Marc A Schneider
Novel Liquid Biomarker Panels for A Very Early Response Capturing of NSCLC Therapies in Advanced Stages. Cancers 12 (4) (2020)
Kati Turkowski, Frederik Herzberg, Stefan Günther, David Brunn, Andreas Weigert, Michael Meister, Thomas Muley, Mark Kriegsmann, Marc A Schneider, Hauke Winter, Michael Thomas, Friedrich Grimminger, Werner Seeger, Soni Savai Pullamsetti, Soni Savai Pullamsetti
Fibroblast Growth Factor-14 Acts as Tumor Suppressor in Lung Adenocarcinomas. Cells 9 (8) (2020)
Sarah Richtmann, Dennis Wilkens, Arne Warth, Felix Lasitschka, Hauke Winter, Petros Christopoulos, Felix J F Herth, Thomas Muley, Michael Meister, Marc A Schneider
FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC. Cancers 11 (5) (2019)
Marc A Schneider, Thomas Muley, Rebecca Weber, Sabine Wessels, Michael Thomas, Felix J F Herth, Nicolas C Kahn, Ralf Eberhardt, Hauke Winter, Gudula Heussel, Arne Warth, Christel Herold-Mende, Michael Meister
Glycodelin as a Serum and Tissue Biomarker for Metastatic and Advanced NSCLC. Cancers 10 (12) (2018)
Grazyna Kwapiszewska, Anna Gungl, Jochen Wilhelm, Leigh Matthew Marsh, Helene Thekkekara Puthenparampil, Katharina Sinn, Miroslava Didiasova, Walter Klepetko, Djuro Kosanovic, Ralph T Schermuly, Lukasz Wujak, Benjamin Weiss, Liliana Schaefer, Marc A Schneider, Michael Kreuter, Andrea Olschewski, Werner Seeger, Horst Olschewski, Malgorzata Wygrecka
Transcriptome profiling reveals the complexity of pirfenidone effects in idiopathic pulmonary fibrosis. The European respiratory journal 52 (5) (2018)
Julia Jabs, Franziska Maria Zickgraf, Jeongbin Park, Steve Wagner, Xiaoqi Jiang, Katharina Jechow, Kortine Kleinheinz, Umut H Toprak, Marc A Schneider, Michael Meister, Saskia Spaich, Marc Sütterlin, Matthias Schlesner, Andreas Trumpp, Martin R Sprick, Roland Eils, Christian Conrad
Screening drug effects in patient-derived cancer cells links organoid responses to genome alterations. Molecular systems biology 13 (11) (2017)

Marc A Schneider.css-eqlu8i{font-size:small;padding-left:4px;} (Marc Schneider, M A Schneider)

Publication Activity (10 Years)

Top Topics

Top Venues

Marc A Schneider (Marc Schneider, M A Schneider)